×
Medtronic Inventory 2010-2024 | MDT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Medtronic inventory for the quarter ending October 31, 2024 was
$5.414B
, a
4.48% decline
year-over-year.
Medtronic inventory for 2024 was
$5.217B
, a
1.44% decline
from 2023.
Medtronic inventory for 2023 was
$5.293B
, a
14.67% increase
from 2022.
Medtronic inventory for 2022 was
$4.616B
, a
7.03% increase
from 2021.
View More
Medtronic Inventory 2010-2024 | MDT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Medtronic inventory for 2024 was
$5.217B
, a
1.44% decline
from 2023.
Medtronic inventory for 2023 was
$5.293B
, a
14.67% increase
from 2022.
Medtronic inventory for 2022 was
$4.616B
, a
7.03% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$203.2B
Stryker (SYK)
$148.2B
Boston Scientific (BSX)
$133.1B
EssilorLuxottica (ESLOY)
$113.5B
Haleon (HLN)
$42.9B
Lonza Group Ag (LZAGY)
$42.1B
GE HealthCare Technologies (GEHC)
$37.7B
ResMed (RMD)
$35B
Terumo (TRUMY)
$29.2B
Koninklijke Philips (PHG)
$24.4B
Zimmer Biomet Holdings (ZBH)
$22.1B
Insulet (PODD)
$18.4B
Baxter (BAX)
$16.6B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.5B
Bio-Rad Laboratories (BIO)
$9B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$5.5B
TG Therapeutics (TGTX)
$4.7B
Haemonetics (HAE)
$4.3B
ICU Medical (ICUI)
$4.2B
Prestige Consumer Healthcare (PBH)
$4.1B
Perrigo (PRGO)
$3.7B
Envista Holdings (NVST)
$3.5B
Neogen (NEOG)
$3.3B
Agios Pharmaceuticals (AGIO)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.8B
QuidelOrtho (QDEL)
$2.6B
Warby Parker (WRBY)
$2.3B